Clonidine Tablet, Extended Release
Product Images NDC 68134-603

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clonidine (NDC 68134-603). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Palmetto Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aglabel (Ag Label)

This is a medication package containing tablets for Clonidine Extended-Release. Each tablet contains 0.17 mg of Clonidine base which is equivalent to 0.2 mg Clonidine hydrochloride. The tablets need to be stored at 20-25°C (56-77°F); keep them in a light-resistant container with a child-resistant closure. This package is meant for dispensing medications under prescription only and should be kept out of reach of children. The GTIN code of the package is 0D0368134603307.*

FDA Label Image

Molecularstructure (Nexiclon Clonidine Extended Release Tablet 1)

FDA Label Image

Figure1 (Nexiclon Clonidine Extended Release Tablet 2)

FDA Label Image

Figure2 (Nexiclon Clonidine Extended Release Tablet 3)

The text provided shows a table that displays the blood pressure measurements (in mmHg) at different timepoints (ranging from 0 to 24 hours) for two drugs: one with an extended-release (ER) dose of 0.6 mg and the other with a twice daily immediate-release (BID IR) dose of 0.3 mg. The table shows systolic and diastolic blood pressure levels at each timepoint for each drug. However, there appears to be some incorrect data in the table (blood pressure readings of 1009 are not possible), making the accuracy of the entire dataset questionable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.